Shenzhen - Delayed Quote CNY

Zhejiang Zhenyuan Share Co.,Ltd. (000705.SZ)

8.58
0.00
(0.00%)
At close: 3:04:24 PM GMT+8
Loading Chart for 000705.SZ
  • Previous Close 8.58
  • Open 8.45
  • Bid 8.57 x --
  • Ask 8.58 x --
  • Day's Range 8.49 - 8.69
  • 52 Week Range 6.75 - 9.28
  • Volume 9,317,800
  • Avg. Volume 10,339,625
  • Market Cap (intraday) 2.867B
  • Beta (5Y Monthly) 0.54
  • PE Ratio (TTM) 57.20
  • EPS (TTM) 0.15
  • Earnings Date --
  • Forward Dividend & Yield 0.06 (0.71%)
  • Ex-Dividend Date Jun 7, 2024
  • 1y Target Est --

Zhejiang Zhenyuan Share Co.,Ltd. manufactures and wholesales pharmaceuticals in China and internationally. It offers Chinese herbal medicines, herbal medicine slices, and patent medicine; and pharmaceutical raw materials, chemical preparations, antibiotics, biochemical drugs, biological products, medical devices, chemical reagents, glass instruments, etc. The company also provides pharmaceutical logistics, health services, etc.; produces, wholesales, and retails medicines, pre-packaged food, and dairy products, such as infant formula milk powder. Zhejiang Zhenyuan Share Co.,Ltd. was founded in 1991 and is based in Shaoxing, China.

www.zjzy.com

2,073

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 000705.SZ

View More

Performance Overview: 000705.SZ

Trailing total returns as of 6/10/2025, which may include dividends or other distributions. Benchmark is 000001.SS (000001.SS) .

YTD Return

000705.SZ
8.47%
000001.SS (000001.SS)
0.99%

1-Year Return

000705.SZ
17.86%
000001.SS (000001.SS)
10.93%

3-Year Return

000705.SZ
8.70%
000001.SS (000001.SS)
3.04%

5-Year Return

000705.SZ
27.69%
000001.SS (000001.SS)
14.98%

Compare To: 000705.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 000705.SZ

View More

Valuation Measures

Annual
As of 6/9/2025
  • Market Cap

    2.87B

  • Enterprise Value

    2.64B

  • Trailing P/E

    57.28

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.86

  • Price/Book (mrq)

    1.43

  • Enterprise Value/Revenue

    0.76

  • Enterprise Value/EBITDA

    35.01

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.49%

  • Return on Assets (ttm)

    0.58%

  • Return on Equity (ttm)

    2.59%

  • Revenue (ttm)

    3.45B

  • Net Income Avi to Common (ttm)

    51.37M

  • Diluted EPS (ttm)

    0.15

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    503.33M

  • Total Debt/Equity (mrq)

    13.56%

  • Levered Free Cash Flow (ttm)

    36.19M

Research Analysis: 000705.SZ

View More

Company Insights: 000705.SZ

Research Reports: 000705.SZ

View More

People Also Watch